X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (53) 53
hematology (51) 51
thalassemia (47) 47
index medicus (46) 46
female (42) 42
adult (40) 40
iran (40) 40
male (39) 39
young adult (23) 23
adolescent (21) 21
beta-thalassemia (21) 21
biochemistry & molecular biology (21) 21
blood transfusion (19) 19
child (19) 19
genotype (19) 19
middle aged (19) 19
mutation (19) 19
beta-thalassemia - genetics (16) 16
oncology (15) 15
phenotype (15) 15
pediatrics (14) 14
α-thalassemia (14) 14
alpha-globins - genetics (13) 13
original (12) 12
alpha-thalassemia - genetics (11) 11
disease (10) 10
original article (10) 10
thalassemia major (10) 10
alleles (9) 9
alpha-thalassemia (9) 9
beta-globins - genetics (9) 9
beta-thalassemia - therapy (9) 9
diagnosis (9) 9
hb h disease (9) 9
iran - epidemiology (9) 9
spectrum (9) 9
β-thalassemia (9) 9
beta-thalassemia - complications (8) 8
child, preschool (8) 8
deletion (8) 8
gene frequency (8) 8
liver (8) 8
prevalence (8) 8
beta-thalassemia - blood (7) 7
cross-sectional studies (7) 7
dna mutational analysis (7) 7
erythrocyte indices (7) 7
transfusion (7) 7
transfusion reaction (7) 7
beta-thalassemia major (6) 6
cohort studies (6) 6
ferritin (6) 6
heterozygote (6) 6
homozygote (6) 6
hydroxyurea (6) 6
intermedia (6) 6
osteoporosis (6) 6
thalassemia intermedia (6) 6
β-thalassemia major (6) 6
alpha-thalassemia - diagnosis (5) 5
alpha-thalassemia - epidemiology (5) 5
analysis (5) 5
beta-thalassemia - diagnosis (5) 5
beta-thalassemia - epidemiology (5) 5
case-control studies (5) 5
children (5) 5
dna (5) 5
family (5) 5
fetal hemoglobin - genetics (5) 5
genetic aspects (5) 5
genetic testing (5) 5
hemic and lymphatic diseases (5) 5
hemoglobin h - genetics (5) 5
hemoglobins, abnormal - genetics (5) 5
iranian population (5) 5
iron overload (5) 5
magnetic resonance imaging - methods (5) 5
mutations (5) 5
polymorphism, single nucleotide (5) 5
population (5) 5
retrospective studies (5) 5
therapy (5) 5
treatment outcome (5) 5
base sequence (4) 4
beta-thalassemia - drug therapy (4) 4
bone mineral density (4) 4
deferasirox (4) 4
deferoxamine (4) 4
erythropoiesis (4) 4
ferritins - blood (4) 4
gene (4) 4
genetic modifiers (4) 4
health aspects (4) 4
hemoglobin (4) 4
hemosiderosis (4) 4
iron (4) 4
medical research (4) 4
medicine, experimental (4) 4
polymorphism, genetic (4) 4
pregnancy (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Blood Cells, Molecules and Diseases, ISSN 1079-9796, 07/2018, Volume 71, pp. 39 - 44
Sideroblastic anemias are heterogeneous rare hematological disorders, representing diverse phenotypes. In this study, the genetic cause of congenital,... 
SLC25A38 | Congenital sideroblastic anemia | Microcytic hypochromic hemolytic anemia | Whole exome sequencing | Rare blood disorders | DIAGNOSIS | PYRIDOXINE | HEMATOLOGY | 5-AMINOLEVULINATE SYNTHASE | ALAS2 GENE
Journal Article
Pediatric Hematology-Oncology, ISSN 0888-0018, 5/2010, Volume 27, Issue 4, pp. 326 - 327
Journal Article
Complementary Therapies in Medicine, ISSN 0965-2299, 10/2019, Volume 46, pp. 24 - 28
The aim of this study was to determine whether quercetin can reduce iron overload and inflammation in thalassemic patients. Eighty four patients were recruited... 
Clinical trial | Iron | Inflammation | Thalassemia major | Quercetin | Blood transfusions | Pediatrics | Transferrin | C-reactive protein | Disease | Anthropometry | Liver | Ferritin | Clinical trials | Demographics | Hemoglobin | Research centers | Age | Starch | Thalassemia | Tumor necrosis factor-α | Metabolism | Chelation therapy | Patients | Studies | Diet | Diabetes | Binding sites
Journal Article
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, ISSN 1077-4114, 11/2016, Volume 38, Issue 8, pp. 636 - 641
The present study was conducted to compare the coagulation factors between splenectomized and nonsplenectomized thalassemia intermedia (TI) patients as well as... 
HOMOCYSTEINE | THROMBOSIS | IRON | thalassemia intermedia | coagulation | HYPERCOAGULABLE STATE | thromboembolic events | ONCOLOGY | DISEASE | PEDIATRICS | BETA-THALASSEMIA | HEMATOLOGY | splenectomy | MAJOR PATIENTS
Journal Article
Journal of Pediatric Hematology/Oncology, ISSN 1077-4114, 11/2016, Volume 38, Issue 8, pp. 636 - 641
The present study was conducted to compare the coagulation factors between splenectomized and nonsplenectomized thalassemia intermedia (TI) patients as well as... 
thromboembolic events | coagulation | thalassemia intermedia | splenectomy | Fibrin Fibrinogen Degradation Products - analysis | Humans | Male | Blood Coagulation Factor Inhibitors - analysis | Case-Control Studies | Splenectomy | Young Adult | beta-Thalassemia - surgery | Blood Coagulation Factors - analysis | Hemostasis | Adult | Female | beta-Thalassemia - blood
Journal Article
Hemoglobin, ISSN 0363-0269, 01/2019, Volume 43, Issue 1, pp. 34 - 37
β-Thalassemia major (β-TM) patients are at increased risk for cardiovascular diseases. Determination of subclinical cardiac involvement is essential for... 
cardiac T2 | β-Thalassemia major (β-TM) | stress echocardiography | subclinical cardiac dysfunction | beta-Thalassemia major (beta-TM) | BIOCHEMISTRY & MOLECULAR BIOLOGY | DISEASE | LIVER | MYOCARDIAL PERFORMANCE INDEX | PREDICTS MORTALITY | HEMATOLOGY
Journal Article
Pediatric Hematology and Oncology, ISSN 0888-0018, 05/2010, Volume 27, Issue 4, pp. 326 - 327
Journal Article
Apoptosis, ISSN 1360-8185, 2/2010, Volume 15, Issue 2, pp. 196 - 203
Exposure of cells to chemotherapeutic drug doxorubicin, a DNA-damaging agent, induces an increase in the levels and activity of the wild-type p53 protein. Less... 
Biochemistry, general | Biomedicine | Wild-type p53 cancer cells | Oncology | Cancer Research | cAMP | Doxorubicin | Virology | Cell Biology | p53 | Apoptosis | CAMP | P53 | PROTEIN PHOSPHATASE | ACTIVATION | PHOSPHORYLATION | MACROPHAGE APOPTOSIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | DNA-DAMAGE | CANCER | CELL BIOLOGY | INDUCED GENE-EXPRESSION | IN-VIVO | LEUKEMIA-CELLS | IONIZING-RADIATION | Okadaic Acid - pharmacology | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Apoptosis - drug effects | Humans | Phosphoprotein Phosphatases - metabolism | Caspase 3 - metabolism | DNA-Binding Proteins - metabolism | Phosphorylation - drug effects | Protein-Serine-Threonine Kinases - metabolism | Tumor Suppressor Proteins - metabolism | Intracellular Space - drug effects | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - enzymology | Cell Cycle Proteins - metabolism | Protein Phosphatase 2C | Tumor Suppressor Protein p53 - metabolism | bcl-2-Associated X Protein - metabolism | Gene Expression Regulation, Leukemic - drug effects | Ataxia Telangiectasia Mutated Proteins | Phosphoserine - metabolism | Serine - metabolism | Cyclic AMP - pharmacology | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Protein Phosphatase 1 - metabolism | Intracellular Space - metabolism | Protein Phosphatase 2 - metabolism | Cell Line, Tumor | Checkpoint Kinase 2 | DNA Damage | Doxorubicin - pharmacology | Chemotherapy | Anthracyclines | Leukemia | Universities and colleges | Tumor proteins | Cancer
Journal Article
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, ISSN 1077-4114, 07/2017, Volume 39, Issue 5, pp. 337 - 340
The present study was performed to evaluate pancreatic hemosiderosis by means of magnetic resonance imaging (MRI) T2* and its relation to the diabetic state in... 
thalassemia | MRI | diabetes mellitus | ABNORMAL GLUCOSE-TOLERANCE | hemosiderosis | ONCOLOGY | STORES | pancreas | LIVER | PEDIATRICS | BETA-THALASSEMIA | HEMATOLOGY | MAJOR PATIENTS
Journal Article
Journal of Pediatric Hematology/Oncology, ISSN 1077-4114, 01/2017, Volume 39, Issue 5, pp. 337 - 340
Journal Article
Archives of Iranian Medicine, ISSN 1029-2977, 02/2016, Volume 19, Issue 2, pp. 96 - 100
Journal Article
Journal of Renal Injury Prevention, ISSN 2345-2781, 2018, Volume 7, Issue 3, pp. 148 - 151
Journal Article
Complementary Therapies in Medicine, ISSN 0965-2299, 10/2019, Volume 46, p. 24
Keywords Quercetin; Thalassemia major; Iron; Inflammation; Clinical trial Highlights * 42 patients received a 500 mg/day quercetin and 42 others took a 500... 
Medical research | Transferrin | C-reactive protein | Clinical trials | Physiological aspects | Medicine, Experimental | Thalassemia | Inflammation | Research institutes | Blood transfusion | Epidemiology
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.